An advisory panel of the U.S. Centers for Disease Control and Prevention will meet on Nov. 2 to discuss the use of COVID-19 vaccines in children aged between 5 and 11 years. Advisors to the U.S. Food and Drug Administration had on Tuesday voted overwhelmingly to